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Abstract 
Objective: Refeeding in patients with anorexia nervosa (AN) is associated with a risk of 
refeeding syndrome (RS), which is a disruption in metabolism with a variety of features 
including hypophosphatemia. We evaluated the risk factors for refeeding 
hypophosphatemia (RH) during nutritional replenishment in Japanese patients with AN. 
Methods: We retrospectively examined clinical data for 99 female inpatients (mean age 
30.9 ± 10.7 years, range: 9 to 56 years). Results: RH (phosphate <2.3 mg/dL) occurred 
within 4.8 ± 3.7 days of hospital admission and was still observed at 28 days after 
admission in 21 of the 99 cases (21.2%). Oral or intravenous phosphate was given to some 
patients to treat or prevent RH. Patients with RH had a significantly lower body mass index, 
were older, and had higher blood urea nitrogen than those without RH. Severe 
complications associated with RH were recorded in only one patient who showed 
convulsions and disturbed consciousness at day 3 when her serum phosphate level was 
1.5 1.6 mg/dL. Conclusion: The significant risk factors for RH that we identified were lower 
BMI, older age, and higher blood urea nitrogen at admission. No significant difference in 
total energy intake was seen between the RH and no RH groups, suggesting that RH may 
not be entirely correlated with energy intake. Precisely predicting and preventing RH is 
difficult, even in patients with AN who are given phosphate for prophylaxis. Thus, serum 
phosphate levels should be monitored for at least 5-10 days after admission. 
 
Introduction 
Anorexia nervosa (AN) is a lifelong Life-threatening illness with frequent relapses1. 
According to surveys of 10,499 Japanese female students in 1982, 1992, and 2002, the 
point prevalence of AN has dramatically increased from 0.11% in 1982 to 0.43% in 20022. 
Effective treatment of patients with AN always starts with nutritional rehabilitation and 
weight restoration. However, insufficient research in the field of refeeding malnourished 
patients has resulted in a lack of consensus and ambivalence about the appropriate initial 
refeeding intake, and consequently, refeeding practices remain inconsistent3,4. The main 
safety concern in treating AN is refeeding syndrome (RS), which is a disruption in 
metabolism characterized by hypophosphatemia, hypomagnesemia, hypokalemia, and 
hypoglycemia5. In its most severe form, RS is associated with cardiac arrhythmia, delirium, 
and sudden death. RS can be treated or prevented with early diagnosis and a slow rate of 
refeeding6.  
Refeeding hypophosphatemia (RH) is typically used as a surrogate for RS5. The rate 
of RH in patients with AN ranges widely from 14% in adolescents7 to 45% in adults8. RH 
range varies from 0% to 45%. (19, 20, 21) Common practice involves beginning with low-
energy intake that is increased slowly to avoid RH. However, very low energy intake can 
lead to insufficient weight gain9. The severity of malnutrition is a better predictor of the 
development of RH than total energy intake in adolescents7. The severity of malnutrition 
(%mBMI: percentage median body mass index for age-and-sex; average 77.9%) is a better 
predictor of the development of RH than total energy intake in adolescents7. However, no 
clinical features predict RH in adults including admission body mass index (BMI) and initial 
amount of energy intake8. The most important issue concerning RH prevention is predicting 
its occurrence from risk factors, because RH onset can be very rapid, sometimes within 
hours days (22, 23, 24). The aim of this study was to evaluate the risk factors for RH during 
nutritional replenishment in a sample of Japanese inpatients with AN.  
Materials and Methods 
  A total of 126 admissions (N = 72 participants) of patients with AN (seven men [5.6%] and 
119 women [94.4%]) consistent with ICD-10 diagnostic criteria occurred to the psychiatric 
ward in Tokushima University Hospital from January 2006 through December 2013. The 
Institutional Review Board approved the study. Ultimately, 99 (N = 61 participants) of the 
126 (78.6%) admissions with AN who were female and whose BMI was under 17.5 kg/m2 
were enrolled in the study. Because %mBMI in 11 cases of adolescents (54.8%~84.1%) 
was significantly correlated with their absolute BMI (r=0.773 p=0.005, Spearman correlation 
test), we applied absolute BMI for both adolescents and adults. The mean age of the 
patients at their initial hospitalization was 30.9 ± 10.7 years (range: 9 to 56 years). The 
mean length of stay in the hospital was 82.7 ± 77.8 days (range: 1 to 312 days). The 
enrolled patients were examined and diagnosed by individual consultant psychiatrists in our 
department. Their diagnoses at intake were also checked by various psychiatrists during a 
conference. A retrospective chart review was independently conducted by at least two 
trained psychiatrists (N.K. and J.I.).  
  Data were extracted from paper and electronic medical records. We documented the 
reason for admission, relevant medical history, demographics, and anthropometric and 
clinical data at hospital admission. Energy intake (kcal), liquids, and electrolyte substitutions 
were recorded for the duration of the hospital stay. Basically, we used low-calorie approach. 
Total energy intake at admission refers to the average total energy intake from day 1 
through day 7. We consulted about the amount of energy intake with the nutrition support 
team depending on the amount of energy intake just before admission, blood test data and 
patient’s acceptance in acute phase treatment. Mean energy intake was increased to over 
1500kcal/day at discharge in most cases. 
  Hematologic and biochemical analyses were performed in the hospital’s central laboratory 
with standard methods and reference measurements. Laboratory data were evaluated from 




During the 28-day follow-up, RH (phosphate <2.3 mg/dL) was observed at least one time 
in 21 of the 99 cases (21.2%). The mean time between admission and occurrence of RH 
was 4.8 ± 7.7 days. Among patients with RH (N = 21), 16 patients (76.2%) received 
phosphate orally or intravenously to treat the hypophosphatemia, and four patients (19.0%) 
received phosphate for 9.6 ± 6.9 days for prophylaxis. We used prophylactic phosphate 
when patients were admitted to the hospital on the weekend, because we could not 
examine the serum phosphate level on the weekend. Among patients without RH (N = 78), 
eight patients (10.3%) received phosphate for 7.4 ± 7.8 days for prophylaxis. A comparison 
of clinical variables in patients with and without RH is presented in Table 1. Patients with 
RH were characterized by a significantly lower BMI, older age, and higher blood urea 
nitrogen (BUN) at admission. The groups did not differ regarding any other characteristics 
including total energy intake at admission. Binominal regression analysis that include age 
at admission, BMI at admission and BUN/Cre ratio revealed BUN/Cre ratio was remained 
to be statistically significant ( Odds Ratio:1.062, 95% C.I: 1.019-1.106). 
Redgrave et al found that there was no association between age and RH in their binomial 
regression model that included age, sex, admission BMI, inpatient rate of weight gain, and 
whether or not the patient had multiple admissions to the program during the study period. 
The difference in findings may come from not only BMI but also other physical co-
morbidities in severe AN. 
Time course of RH 
The mean and minimum serum phosphate levels in the RH group and the no RH group 
are depicted in Figures 1, respectively. RH occurred at 4.8 ± 3.7 days after admission. Five 
patients in the RH group showed hypophosphatemia at admission. Two patients in the RH 
group were first admitted to the internal medicine ward without checking serum phosphate 
levels and were then transferred to the psychiatric ward and found to have 
hypophosphatemia. Among patients whose serum phosphate levels were checked at 
admission, the first day at which hypophosphatemia was observed ranged from day 1 to 
day 10. All RH cases including the two patients who were first admitted to the internal 
medicine ward had recovered by day 19. 
RH-related complications 
  In the RH group, severe complications associated with RH were recorded in only one 
patient. The 50-year-old patient (BMI: 10.6 kg/m2) showed convulsions and disturbed 
consciousness at day 3 when her serum phosphate level was 1.6 mg/dL. The lowest serum 
phosphate level (0.3 mg/dL) in this series of patients was observed in a 30-year-old patient 
(BMI: 9.7 kg/m2). In this patient, hypophosphatemia was found with a regular blood test in 
the outpatient clinic, and the patient was transferred to the psychiatric ward on the same 
day. She was conscious and alert and showed no subjective symptoms. For several days 
before her regular visit, she increased her energy intake to avoid involuntary admission. 
Her hypophosphatemia had recovered by day 6.  
Discussion 
  A recent review7 identified a wide range in refeeding rates (125-1900 kcal/day), which may 
be due to the unpredictable presentation of RH coupled with insufficient research into 
interventions in the area of refeeding malnourished patients. The absence of data has 
hindered the development of comprehensive global refeeding guidelines. A noticeable 
difference is seen in proposed guidelines for refeeding rates adopted in Europe and 
Australia compared to North America. The European and Australian guidelines recommend 
that refeeding commence more conservatively than American recommendations: 5-20 
kcal/kg10,11 and 30-40 kcal/kg12, respectively. The recommended refeeding guidelines were 
based on clinical experience rather than scientific evidence. In this study, total energy 
intake was within the recommended rate, and no significant difference between the RH 
group and no RH group was seen. Our result suggests that RH may not be entirely 
correlated with energy intake. 
  The significant risk factors for RH that we identified in our study were lower BMI, older age, 
and higher BUN at admission. Many studies have reported that the lowest refeeding 
phosphate level is directly proportional to malnutrition13,14,15. A recent systematic review 
also indicated that the severity of malnutrition was a better marker for the development of 
RH than total energy intake7.  
To the best of our knowledge, this is the first report showing that older age may be a risk 
factor for RH. In general, older patients have a longer illness duration, longer-term 
malnutrition, and more physical complications. Age-related impairment of physical function 
or low reserve function caused by the longer disease duration may be associated with this 
result. The estimated time of illness of the 99 patients in our study was 10.8 ± 8.4 years and 
was significantly correlated with the age at admission (r = 0.76, P < 0.05, Spearman 
correlation test). All patients whose estimated time of illness was less than 1 year (n = 6) 
did not present with hypophosphatemia. Although chronicity was thought to be protective 
from RS due to malnutrition adaptation, age-related impairment of physical function or low 
reserve function caused by a longer disease duration may be associated with this result. 
(16, 17, 18) 
Higher BUN and BUN/Creatine ratio may be risk factors for RH. Dehydration is 
suggested if the BUN/Cre ratio is above 10. At admission, 80% of the patients in our study 
had a BUN/Cre ratio above 10, and intravenous dripping promptly decreased their BUN 
and Hematocrit. Thus, a higher BUN or BUN/Cre ratio seems to be associated with 
dehydration. In this study, BMI and the BUN/Cre ratio at admission were negatively 
correlated (r = −0.61, P < 0.001). Dehydration and severe malnutrition often co-exist in 
severe AN. Consistent with this result, drastic malnutrition such as unintentional weight loss 
greater than 15% over the previous 3-6 months body weight lost and little or no nutritional 
intake for more than 10 days renders a patient at high risk for developing refeeding 
problems, according to the National Institute for Health and Care Excellence (NICE) 
guidelines (25).  
  The observation that RH occurred at 4.8 ± 7.7 days after admission is important. As far as 
we know, no clinical recommendations exist for the follow-up period of RH. According to our 
result, follow-up measurement of serum phosphate may be necessary for at least 5-10 
days  more than 5 days in patients with AN at high risk for RH. 
  The main limitation of our study is that patients were retrospectively studied. The 
present findings are limited to severe, hospitalized cases and therefore cannot be 
generalized to outpatient or community samples. We did not examine other complications 
of RS such as hypomagnesemia, hypokalemia, and hypoglycemia. Finally, treatment was 
not controlled for this study, and patients received a variety of treatments during follow-up.  
 
Conclusion 
  Our data indicate that lower BMI, older age, and higher BUN (dehydration), but not total 
energy intake, at admission are significant risk factors for RH. Because precisely predicting 
and preventing RH is difficult, even in patients with AN who are given phosphate for 
prophylaxis, serum phosphate levels should be monitored for at least 5-10 days more than 
5 days after admission.  
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Table 1. Comparison of clinical variables in patients with and without refeeding 
hypophosphatemia.  
 
 RH group (N = 21) No RH group (N = 
78) 
P value 
BMI at admission (kg/m2) 
Age at admission (years) 
Total energy intake (kcal/day) 
11.00 ± 2.34  
36.0 ± 8.4 
858.8 ± 353.5  
13.17 ± 2.24  
29.5 ± 10.8  









































136.0 ± 5.9 
3.51 ± 0.62 
94.2 ± 14.6 
8.75 ± 1.05 
2.25 ± 0.50 
3.46 ± 2.16 
3.788 ± 0.763 
11.94 ± 2.34 
34.71 ± 6.28 
166.0 ± 216.9 
133.4 ± 204.7 
74.1 ± 77.9 
76.8 ± 40.1 
3.25 ± 0.71 
31.5 ± 15.9 
1.043 ± 1.264 
45.03 ± 28.18 
 
136.4 ± 6.2 
3.76 ± 1.18 
91.7 ± 16.2 
9.21 ± 0.75 
2.22 ± 0.33 
4.51 ± 2.23 
3.955 ± 0.792 
11.87 ± 0.39 
35.17 ± 6.57 
80.8 ± 162.6 
69.3 ± 154.1 
75.4 ± 152.7 
77.5 ± 40.3 
3.68 ± 0.80 
21.3 ± 17.4 
1.492 ± 2.018 


















0.001   
Student’s t-test was used for analyses. The data are the mean ± standard deviation. 
Abbreviations: Na: Sodium, K: Potassium, Cl: Chloride, Ca: Total calcium, Mg: Magnesium, 
P: Phosphate, RBC: Red blood cells, HGB: Hemoglobin, HCT: Hematocrit, AST: Aspartate 
transaminase, ALT: Alanine transaminase, γ-GTP: Gamma glutamyl transferase, FBS: 
Fasting blood sugar, ALB: Albumin, BUN: Blood urea nitrogen, Cre: Creatinine, BUN/Cre: 











Figure 1. Mean and minimum serum phosphate level in the RH group (A) and the No-RH 
group (B) during the first 28 days after admission.  
 
